Leaders' Update 
A message from Director Gordon Ginder
This message continues with:
|
Drug combination therapy causes cancer cells to "eat themselves"
A recent preclinical study has confirmed that a combination of sorafenib, regorafenib and PI3K/AKT inhibitors synergize to kill a variety of cancers. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
|
Massey's BMT unit first of its kind in nation to receive prestigious Beacon Award
 The inpatient bone marrow transplant (BMT) unit at Massey is the first of its kind in the nation to earn the American Association of Critical-Care Nurses (AACN) Beacon Award for Excellence, which recognizes individual units that distinguish themselves by improving every facet of patient care. This highly regarded award is a significant achievement for a hospital unit and signifies a commitment to patient safety and satisfaction.
|
Massey first in Richmond to offer cutting-edge therapy for metastatic prostate cancer
 Massey is the only cancer care provider in the Richmond metropolitan region to offer radium-223, an innovative, new drug that has been shown to increase survival and quality of life in patients with metastatic castration-resistant prostate cancer (CRPC).
|
Member Showcase
Park studies RNA splicing
Massey welcomes Margaret A. Park, Ph.D., as a new member of the Cancer Cell Signaling program. Her research interests are in RNA splicing, especially as it relates to metastasis and related pathways, cell death and autophagy regulation, cell signaling, combination inhibitor therapies for cancer and systems biology.
Park is also a Center for Clinical and Translational Research KL2 Scholar award recipient.
|
Krist receives NIH grant to study a new system for cancer screenings
Alex Krist, M.P.H., M.D., has received a multi-year, multi-phase grant from the National Institutes of Health (NIH) to measure whether making personal health records with higher functionality available to primary care physicians and patients will promote shared health decision-making and increase the use of cancer screening compared to existing information systems.
|
